Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0TW9N
|
||||
| Former ID |
DNC008727
|
||||
| Drug Name |
2-((2-ethoxyphenoxy)methyl)-4-isopropylmorpholine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C16H25NO3
|
||||
| Canonical SMILES |
CCOC1=CC=CC=C1OCC2CN(CCO2)C(C)C
|
||||
| InChI |
1S/C16H25NO3/c1-4-18-15-7-5-6-8-16(15)20-12-14-11-17(13(2)3)9-10-19-14/h5-8,13-14H,4,9-12H2,1-3H3
|
||||
| InChIKey |
YIUUQQVMBNHWQV-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Histamine H3 receptor | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| Reactome | Histamine receptors | ||||
| G alpha (i) signalling events | |||||
| WikiPathways | Monoamine Transport | ||||
| GPCRs, Class A Rhodopsin-like | |||||
| GPCR ligand binding | |||||
| GPCR downstream signaling | |||||
| References | |||||
| REF 1 | Bioorg Med Chem Lett. 2008 Nov 1;18(21):5796-9. Epub 2008 Sep 24.2-Aryloxymethylmorpholine histamine H(3) antagonists. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.